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Background: Hepatic resection in patients with chronic liver disease (CLD) is associated with a risk of
post-operative liver failure and higher morbidity than patients without liver disease. There is no universal
risk stratification scheme for CLD patients undergoing resection.
Objectives: The aim of the present study was to evaluate the association between routine pre-operative
laboratory investigations, model for end-stage liver disease (MELD), indocyanine green retention at
15 min (ICG15) and post-operative outcomes in CLD patients undergoing liver resection.
Methods: A retrospective review of patients undergoing resection for hepatocellular carcinoma (HCC) at
the University Health Network was preformed. ICG15 results, pre- and post-operative laboratory results
were obtained from clinical records. Adjusted odds ratios (AOR) were calculated for associations between
pre-operative factors and post-operative outcomes using multivariate logistic regression adjusting for
patient age and number of segments resected.
Results: Between 2001 and 2005, 129 CLD patients underwent surgical resection for HCC. Procedures
included 51 (40%) resections of 2 segments, 52 (40%) hemihepatectomies and 25 (19%) extended
hepatic resections. Thirty- and 90-day post-operative mortality was 1.6% and 4.1%, respectively. Pro-
longed (>10 days) hospital length of stay (LOS) was independently associated with an ICG15 >15% {AOR
[95% confidence interval (CI)] = 8.5 (1.4–51)} and an international normalized ratio (INR) > 1.2 [AOR (95%
CI) = 5.0 (1.4–18.6)]. An ICG15 > 15% and MELD score were independent predictors of prolonged LOS.
An ICG15 > 15% was also independently associated with MELD > 20 on post-operative day 3 [AOR (95%
CI) = 24.3 (1.8–319)].
Conclusions: Elevated ICG retention was independently associated with post-operative liver dysfunc-
tion and morbidity. The utility of ICG in combination with other biochemical measures to predict outcomes
after hepatic resection in CLD patients requires further prospective study.
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Introduction
The management of hepatocellular carcinoma (HCC) is compli-
cated by the concurrent existence of primary hepatic malignancy
and predisposing chronic liver disease (CLD). Hepatic resection is
the primary treatment option for patients with early HCC (BCLC-
A/B) with relatively preserved liver function and no portal hyper-
tension.1,2 However, it is well recognized that patients with a
background of CLD who undergo resection have a higher risk of
post-operative morbidity and hepatic dysfunction compared with
patients without liver disease. Common aetiologies of CLD in
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North America include hepatitis B, hepatitis C, alcohol use,
autoimmune hepatitis, as well as non-alcoholic steatohepatitis
and all predispose patients to the development of hepatic fibrosis,
cirrhosis and HCC. Currently there is no universal validated risk
stratification scheme for patients with CLD undergoing hepatic
resection. Multiple clinical parameters can be used to assess a
patient’s liver function before resection including: the interna-
tional normalized ratio (INR), platelet count, serum albumin,
creatinine, bilirubin levels, the presence of ascites, oesophageal
varices, hepato-splenomegaly, hepatic venous pressure gradient or
other signs of portal hypertension. Individually, these parameters
have limited ability to stratify operative risks of CLD patients
undergoing surgery. Composite measures of laboratory and clini-
cal parameters including the Child–Pugh Score (CPS) and the
model for end-stage liver disease (MELD) can be a better global
measure of liver function or CLD and can predict mortality for
patients undergoing transjugular intrahepatic portosystemic
shunt procedures or orthotopic liver transplantation, respectively.
However, none of these individual or composite measures of
hepatic function have been successfully used pre-operatively to
predict liver dysfunction, morbidity or mortality in patients with
CLD undergoing hepatic resection. Several groups have examined
the utility portal pressure measurements3 or MELD score4,5 in
predicting post-operative hepatic dysfunction but neither has
been conclusively validated.
The indocyanine green (ICG) clearance test was developed to
assess the dynamic functionality of the liver and has been sug-
gested as a potential predictor of CLD patients suitability for
hepatic resection.6,7 ICG is a dark blue–green tricarbocyanine dye
that is completely and exclusively removed by the liver and
excreted into the bile. It does not undergo any intrahepatic con-
jugation or enterohepatic circulation. Previous studies have
shown that the normal ICG retention at 15 min ranges from 8%
to 14%.8 In patients with clearance kinetics above this cutoff value,
hepatic resection may be associated with an increased risk of
post-operative hepatic dysfunction.
Post-operative hepatic dysfunction is a major source of the
increased risk of morbidity and mortality in CLD patients under-
going liver resection.9 However, there is no universally accepted
risk stratification scheme used for patients with CLD undergoing
hepatic resection for HCC. The aim of the present study was to
determine factors associated with post-operative liver dysfunction
and prolonged length of stay (LOS) in patients with CLD under-
going liver resection for HCC. In particular, we evaluate the asso-
ciation between pre-operative laboratory markers, MELD, ICG
retention at 15 min (ICG15) and post-operatives outcomes.
Methods
Ethics approval was obtained at the University Health Network. A
retrospective chart review was completed for patients who were
diagnosed with HCC from April 2001 to August 2005, inclusive,
and underwent surgical resection at the University Health
Network. Patients were determined to have chronic liver disease
based on clinical diagnosis, laboratory parameters (e.g. viral serol-
ogy) or liver biopsy performed at some point before evaluation for
surgery. Patients who were subsequently found to have no under-
lying liver disease (steatosis, fibrosis, cirrhosis and active hepatitis)
on pathological examination of the non-tumour liver specimen
were excluded from the present study. Each patient had a complete
biochemical workup at their first consultation date with the spe-
cialist (hepatologist or hepatobiliary surgeon) and all patients
were evaluated with an ICG retention test.
ICG retention testing was performed according to published
protocols (http://www.casorganic.com). After fasting, the patient
is injected with 0.5 mg/kg of ICG (Akorn Inc., Somerset, NJ, USA)
intravenously, and serial blood samples were drawn at 5, 15, 20, 25
and 30 min after injection. After being processed, the ICG reten-
tion at 15 min is obtained as a percentage.9 Based on available
data, ICG retention of >15% at 15 min was felt to be indicative of
decreased ICG clearance and impaired hepatic function.6,8 Liver
volumetry, portal vein embolization and a pre-operative liver
biopsy were not routinely utilized during the study period in the
assessment or preparation of patients for surgery.
All patients included in this series (2001 to 2005) underwent an
open hepatic resection via a right subcostal incision with midline
extension.10 Our institutional policy is to perform a parenchymal-
preserving resection with adequate (>1 cm) margins to obtain an
R0 resection. The type of resection was determined by the surgical
team based on the tumour size as well as location and proximity to
major vascular structures. Vascular inflow and outflow structures
were divided before hepatic transection for hepatic lobectomies.
Parenchymal transection was performed using Helix Hydro-Jet™
(ERBE Inc., Marietta, GA, USA) and electrocautery under low
central-venous pressure conditions as previously described.2,11
Intermittent portal inflow occlusion (Pringle Manoeuver) was
performed selectively at the discretion of the operating surgeon.
Operative details and post-operative outcomes were deter-
mined through review of the patient’s clinical chart. Laboratory
parameters on days 1, 3, 5 and 6 months post-resection, including
creatinine, albumin, INR and platelets, were obtained. Post-
operative mortality was defined as death from any cause 30 or 90
days post-resection. The primary end points analysed were LOS
and post-operative liver dysfunction. There were insufficient
events to specifically analyse mortality or individual causes of
morbidity. Therefore, as many morbidity rating scales consider
events which prolong hospital stay to be significant, we analysed
the distribution of LOS in the present study group. Based on the
observed distributions, a LOS > 10 days was considered prolonged
(i.e. >75th percentile) and indicative of overall post-operative
morbidity. Similarly, post-operative liver dysfunction was exam-
ined by analysing clinical parameters (ascites, encephalopathy and
renal dysfunction) as well as a rise in biochemical parameters
(INR, bilirubin and creatinine) and composite measures including
MELD and Childs score on post-operative days 1, 3 and 5. Several
cut-off and time points were examined for each biochemical
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parameter including ICG retention. A rise in post-operative
MELD score appeared to be the most consistent and discrimina-
tive overall measure of liver dysfunction with scores of >20 on day
312–14 indicative of moderate-to-severe liver failure.
To identify pre-operative factors associated with prolonged LOS
(>10 days) or post-operative liver dysfunction, we analysed factors
using backwards unconditional logistic regression. All multivari-
able models included age and number of segments resected. The
pre-operative factors analysed were creatinine (Cr), platelets (plt),
bilirubin (bili), ICG15 > 15, INR, albumin (alb) and a pre-
operative MELD score >14. To reduce the effect of covariance in
analyses including pre-operativeMELD scores, the components of
MELD (bilirubin, INR and creatinine) were removed from
the multivariable models. Multivariable odds ratios (MVOR),
adjusting for patient age and number of segments resected, were
calculated for the associations between pre-operative factors and
post-operative outcomes. A two-sided P-value < 0.05 was consid-
ered significant.
Results
One hundred and twenty-nine patients with a diagnosis of HCC
underwent a hepatic resection. The age of the patients ranged
from 17 to 84 years (median = 58 years). The male-to-female ratio
was 108 : 21. Patients’ underlying liver disease included hepatitis B
in 78 (60.1%), hepatitis C in 29 (22%) and alcohol in 14 (11%).
While a liver biopsy was not performed in the routine evaluation
of surgical patients, 80 (63%) patients had had a previous percu-
taneous biopsy documenting cirrhosis. Table 1 describes the
demographics, aetiology of liver disease, pre-operative laboratory
results and type of operations. Ten patients had an ICG15  15
and six patients had a pre-operative MELD score 14. The vast
majority of patients (n = 121, 94%) were Childs A whereas seven
patients were Childs B. Five patients underwent pre-operative
portal vein embolization to induce hypertrophy of the future
remnant liver before a hemihepatectomy. Three patients had
undergone previous percutaneous treatment and four patients
had a prior surgical resection for HCC.
Surgical resections included 51 minor hepatectomies (2 seg-
ments), 52 hepatic lobectomies and 25 extended hepatic resec-
tions. Three patients had radiofrequency ablation in addition to
their resection at the time of surgery. One hundred and four
patients underwent surgery for a solitary tumour whereas 24
patients had resection of multiple malignant lesions (range 2–9).
The median tumour size was 4.5 cm (range 1 cm–24 cm). The
median alpha-fetoprotein level was 41 (range 2–320595). There
were two peri-operative deaths within 30 days, associated with a
myocardial infarction and sepsis, respectively, for a 30-day post-
operative mortality rate of 1.6%. Between 30 and 90 days there
were three deaths, all from liver failure and sepsis, for a total
90-day post-operative mortality of 4%. Four patients required a
second laparotomy during their hospital admission for bleeding
or an intra-abdominal haematoma. Five patients developed docu-
mented pulmonary complications (pneumonia three, pulmonary
emobolism one and respiratory failure one) and four patients
developed cardiac complications (atrial fibrillation two and myo-
cardial infarction two) requiring pharmacological intervention.
Seven patients developed ascites requiring prolonged diuretic
therapy and six patients had documented wound infections. Six
patients developed bilomas or intra-abdominal collections that
required radiology-guided percutaneous drainage.
A backwards conditional regression analysis adjusted for age
and the number of segments resected was used to assess for pre-
dictors of prolonged LOS > 10 days. Factors used in the regression
analysis were Bili, Alb, INR, ICG15 and plt (Table 2).
Regression analysis showed that a prolonged LOS > 10 days was
independently associated with an ICG15  15% {adjusted odds
ratio (AOR) [95% confidence interval (95% CI)] = 8.5 (1.5–51)}
and an INR >1.2 [AOR (95% CI) = 5.0 (1.4–319)].
As several previous publications3–5 had suggested that a MELD
scoremay have some utility in predicting post-operative outcomes
Table 1 Demographics for patients undergoing hepatic resection
for HCC
n = 129
Gender male : female 108 : 21
Median age (range) 58.03 (17.77–84.79)
Median weight 68.4 kg
Resection of 2 segments (%) 51 (40%)
Hemihepatectomy (%) 52 (40%)
Extended hepatic resection (%) 25 (19%)
Median length of stay (range) 8d (5–48d)
Causes of HCC:
Hepatitis B 78
Hepatitis C 29
Alcohol use 14
Unknown risk factors 11
Other 4
Childs–Pugh Score
5 116
6 5
7 5
8 2
Median pre-operative platelets 190 (79–636)
Median pre-operative creatinine 78 (24–1192)
Median pre-operative albumin 42 (22–54)
Median pre-operative INR 1.06 (0.89–2.22)
Median pre-operative bilirubin 11 (4–31)
Median ICG retention at 15 min (range) 7.45% (1.6–21.5%)
Median pre-operative MELD (range) 7 (5–32)
30 day post-operative mortality 2 (1.6%)
90 day post-operative mortality 5 (4.0%)
HCC, hepatocellular carcinoma; INR, international normalized ratio;
MELD, model of end-stage liver disease.
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after hepatic resection, we repeated the analysis and included the
pre-operative MELD score while excluding the components of
MELD (bilirubin, INR and creatinine) from the models. An
ICG15  15% and pre-operative MELD > 14 were independent
predictors of prolonged LOS > 10 days post-hepatic resection.
A multivariate regression analysis adjusting for patient age and
number of segments resected was used to assess for predictors of
a MELD > 20 on post-operative day 3 as a surrogate for post-
operative liver dysfunction. This analysis revealed that an ICG15
 15% was the only predictor of a MELD score > 20 on post-
operative day 3 (Table 3) with an adjusted OR (95% CI) of 24.3
(1.8–319). Among patients with a MELD > 20 on post-operative
day 3, all of the biochemical components of MELD appeared to be
contributing to rise in MELD score. Significant elevations in
bilirubin (P = 0.009) and INR (P = 0.003) were seen in patients
with a MELD > 20 compared with others while there was a trend
Table 2 Adjusted odds ratio for prolonged length of stay (LOS) > 10 days post-hepatic resection
Factor n Median LOS Univariate analysis P-value Multivariate analysis P-value
AOR (95% CI) AOR (95% CI)
Pre-operative platelets < 100 124 8 2.17 (0.168–28.0) 0.585
3 7
Pre-operative creatinine > 100 102 7 1.29 (0.39–4.23) 0.67
19 8
Pre-operative bilirubin > 15 97 8 1.00 (0.35–2.92) 0.991
28 7
Pre-operative INR > 1.2 111 7 3.98 (1.2–13.7) 0.029 5.0 (1.4–18.6) 0.019
14 9.5
Pre-operative albumi < 40 93 7 2.12 (0.79–5.68) 0.136
29 8
Pre-operative ICG15  15% 115 7.5 5.14 (1.06–25.0) 0.042 8.5 (1.4–51) 0.014
10 13
Pre-operative MELD > 14a 114 7 2.17 (0.35–13.3) 0.40
6 8
aPre-operative MELD was analysed in a separate multivariate analysis, excluding bilirubin, creatinine and INR as variables.
MELD, model of end stage liver disease; INR, international normalized ratio; ICG15, indocyanine green retention at 15 min.
Table 3 Adjusted odds ratio for MELD score > 20 on post-operative day 3
Factor n MELD > 20 Univariate analysis P-value Multivariate analysis P-value
Adjusted odds ratio (95% CI) Adjusted odds ratio (95% CI)
Pre-operativea platelets < 100 124 8
3 0
Pre-operative creatinine > 100 102 5 2.73 (0.40–18.5) 0.30
19 2
Pre-operative bilirubin > 15 88 7 0.47 (0.05–4.47) 0.51
27 1
Pre-operative INR > 1.2 103 6 4.58 (0.68–31) 0.119
12 2
Pre-operative albumin < 40 94 5 2.12 (0.42–10.9) 0.34
29 3
Pre-operative ICG15  15% 108 14 10.2 (1.1–93) 0.04 24.3 (1.8–319) 0.015
8 2
Pre-operative MELD > 14b 107 12 5.89 (0.46–76) 0.17
6 3
aOdds ratios cannot be calculated for platelets <100 as no patients in this category had a MELD score <20 on POD3.
bPre-operative MELD was analysed in a separate multivariate analysis, excluding bilirubin, creatinine and INR as a variable.
MELD, model of end stage liver disease; INR, international normalized ratio; ICG15, indocyanine green retention at 15 min.
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towards a higher creatinine in this group (P = 0.18) indicating that
all components of theMELD score likely contributed to the higher
score in these patients.
Discussion
In the treatment of HCC, surgical resection represents a viable
curative treatment option for patients with limited disease (BCLC
Stage A/B) and relatively preserved liver function.2 However,
resection is associated with significant risks of peri-operative mor-
bidity and liver dysfunction as a result of the presence of concomi-
tant liver disease in this patient population. In determining
individual treatment plans for patients with HCC, the evaluation
of CLD patients for potential resection is hampered by the lack of
any reliable or validated risk stratification scheme to predict peri-
operative risks including post-operative hepatic dysfunction. The
Childs–Pugh score has been used in the past to predict outcomes
in patients with CLD undergoing elective surgery. Patients with
Child–Pugh class C have a higher associated morbidity and mor-
tality after elective surgery compared with those with class A or B.4
The Child–Pugh scoring system was developed for risk assessment
of portal-caval shunt surgery and has many inherent limitations,
including the subjective nature of the scoring system and the
heterogeneity of disease severity of subjects within a scoring class
based on the equal contributions of symptoms or biochemical
parameters with different clinical implications. While many
centres will restrict resection to patients with CPS A or CPS B7
there is significant heterogeneity in post-operative outcome
among patients with identical CPS indicating this scoring system
alone fails to adequately stratify a patient’s ability to tolerate a
minor or major hepatectomy.
More recently MELD has been studied and used to stratify
patients with CLD awaiting liver transplant.14 MELD uses a more
objective scoring system and calculation is used in organ alloca-
tion for transplantation in the US.While MELD was developed to
predict mortality for those awaiting liver transplantation, it has
recently been shown to predict 3-monthmortality in patients with
CLD.5 It has been suggested that patients with a MELD score of
greater than or equal to 14 have a significantly increased risk of
morbidity and poor outcome post-abdominal surgery.5 This
recent data has led some to suggest that MELD replaces Child–
Pugh score in assessing ‘fitness’ for surgery for patients with CLD.
Llovet and Bruix3 analysed elevated portal pressure and biliru-
bin in the outcomes of HCC patients undergoing surgical resec-
tion. They defined clinically relevant portal hypertension as a
hepatic venous pressure gradient greater than 10 mmHg, oesoph-
ageal varices or splenomegaly with a platelet count less than
100 000/mm3.3 Patients with a normal portal pressure and biliru-
bin had a 70% survival rate at 5 years and this survival rate was
significantly higher than those with portal hypertension and/or an
increased bilirubin (50% and 25% for patient with moderate and
severe clinically relevant portal hypertension, respectively).3 The
present study suggests that the clinically relevant portal hyperten-
sion calculation should be used as a predictor for post-surgical
outcome. While these authors acknowledge the use of ICG clear-
ance in Japanese centres, it was suggested that clinically relevant
portal hypertension may be a more widely applicable predictor of
outcome as ICG is used sparingly in North America and Europe.
Very few patients in our series had evidence of platelet sequestra-
tion due to portal hypertension so it is difficult to make any
definitive conclusions on the value of platelet counts to determine
post-operative outcomes. Teh et al.4 have shown a MELD  9 is
strongly predictive of peri-operative mortality in patients with
CLD that are undergoing hepatic resection. They also found that
clinical tumour symptoms and an American Society of Anesthe-
siologists (ASA) score 3 was significant for predicting peri-
operative mortality. Befeler et al.5 found aMELD score of14 was
a better predictor of poor outcome for patients with cirrhosis
undergoing abdominal surgery than the Childs–Pugh score. In the
present study, patients undergoing hepatic surgery were excluded.
Cumulatively, it seems there is a paucity of research on ICG clear-
ance and its predictive ability for peri-operative mortality in
patients undergoing hepatic resection with CLD.
In 1992, Hemming et al.15 published a study that looked at the
role of ICG clearance in predicting the prognosis of patients with
CLD undergoing hepatic resection. In their study of 22 patients,
four died peri-operatively from hepatic failure. They found the
ICG clearance rate of survivors was 7.7 (standard error of the
mean, SEM 0.7) ml/min/kg, and rates for non-survivors was 2.5
(SEM 0.3) ml/min/kg. They found a discriminant cutoff of 5.2 ml/
min/kg for the ICG clearance rate.15 Although the previous study
analysed ICG retention, the idea that using ICG to assess synthetic
hepatic function and its predictability for peri-operative morbid-
ity and mortality is consistent with the findings in the present
study. Similarly, Sheng et al.16 found that ICG clearance was a good
parameter to evaluate liver function. The previous study assessed
the correlation betweenMELD and ICG clearance in patients with
CLD. They found that as the Child–Pugh score increased, the ICG
clearance rate decreased, ICG retention increased and the MELD
score increased; ICG clearance was negatively correlated with the
MELD score (r = -0.892, P < 0.05) and ICG retention was posi-
tively correlated with the MELD score (r = 0.804, P < 0.05).15 The
present study showed that only ICG retention was independently
predictive of peri-operative LOS and hepatic dysfunction.
Although Sheng et al.16 found MELD and ICG to be correlated for
predicting liver function in patients with CLD, the data presented
would appear to support that ICG and MELD may be indepen-
dently associated with morbidity.
The ICG15 retention test is an additional test utilized by some
centres as an evaluation tool of dynamic liver function in patients
being assessed for hepatic resection. This dye is exclusively
removed by the liver and excreted into the bile without undergo-
ing intra-hepatic conjugation. Normal ICG retention at 15 min
ranges from 8% to 14%.8 The present study population consisted
of patients with an ICG15 ranging from 2.2% to 25%, indicating
a broad range in the severity of underlying liver disease. Similarly,
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the MELD score ranged from 5 to 32 in the present study popu-
lation. The study results suggest that an elevated ICG15 retention
above 14% is associated with prolonged LOS above 10 days, post-
operative liver dysfunction and morbidity. The ICG15 threshold
of 14% was selected based on the observed distribution of ICG15
values in the present study cohort and coincides with the upper
limit of normal in previously published series.8 The clinical utility
of this cut point is subject to validation in future studies. An
elevated MELD score above 14 was only predictive of prolonged
LOS but it was not found to be an independent predictor of
post-operative liver dysfunction. In addition we found that an
increased ICG15 above 14% is a predictor of an increased MELD
score above 20 post-operatively, and therefore predictive of post-
operative liver dysfunction.
Cucchetti et al.13 investigated the role of MELD in predicting
post-operative liver dysfunction and mortality in patients under-
going a hepatectomy for HCC with CLD. They looked at a cohort
of 154 patients retrospectively and analysed the post-operative
MELD score, liver failure, post-operative complications, LOS and
1-year survival using receiver-operating characteristics.13 They
found patients with a pre-operative MELD score greater than 1117
to have an increased risk of post-operative liver failure and a
post-operative MELD score of greater than 9 to have an increased
risk of post-operative complications13; thus, they concluded that a
MELD score could predict post-operative liver failure and mor-
bidity post-operatively and should be used to select patients for
undergoing hepatic resection.13,17 They examined the pre-
operative MELD score and defined post-operative liver failure as
growing impairment of liver function after resection that led to
patient death or transplantation. The majority of the population
in the previous study underwent minor hepatic resections, that is,
segmentectomies and wedge resections. This differs from the
present study where the majority of patients underwent major
hepatic resections (right and extended right hepatectomies) and
may explain the different findings in this series.
Limitations of the present study include the small sample size
used and as such we were unable to investigate the predictive
mortality of ICG15 or MELD as a result of our low death rates in
this series. As ICG15 was used in the clinical assessment of
patients before surgery, we cannot exclude the potential of selec-
tion bias in excluding patients with significantly elevated ICG
retention who may have benefited from surgery but were deemed
non-operative candidates because of this result. However, the
present study is a starting point for a larger-scale study that looks
at patients with CLD undergoing hepatic resection to assess the
post-operative predictive mortality of patients. Also, a more
detailed analysis identifying if a MELD > 14 or INR > 1.2 is a
better predictor of prolonged LOS > 10 days.
Taken together the data presented suggest that ICG15 is an
excellent predictor of post-operative liver failure and morbidity in
patients requiring major hepatic resections and may be used in
combination with other biochemical parameters (including
MELD) in assessing CLD patients before hepatic resection. Fur-
thermore, while the MELD score may have some utility in the
pre-operative assessment of CLD patients, it appears that ICG and
MELD are independently associated with post-operative morbid-
ity. It is possible that these tests evaluate different parameters of
hepatic function, with ICG and MELD values indicative of excre-
tion and synthetic function, respectively. These results would
suggest that the addition of ICG measurements to traditional
biochemical assessments of hepatic function, such as MELD, may
improve the pre-operative evaluation of risk in this population.
Thus, the utility of ICG15 retention in combination with other
biochemical measures (such as the MELD score) to predict out-
comes after hepatic resection in CLD patients requires further
study.
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